1. Trends in co-prescribing of opioids and opioid potentiators among U.S. adults, 2007-2018;Rhee;Am J Prev Med,2021
2. Gabapentinoid use in the United States 2002 through 2015;Johansen;JAMA Intern Med,2018
3. American Geriatrics Society 2019 updated AGS Beers Criteria® for potentially inappropriate medication use in older adults;J Am Geriatr Soc,2019
4. U.S. Food & Drug Administration. FDA Drug Safety Communication: FDA warns about serious risks and death when combining opioid pain or cough medicines with benzodiazepines; requires its strongest warning. Accessed February 11, 2021. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-about-serious-risks-and-death-when-combining-opioid-pain-or
5. U.S. Food & Drug Administration. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR). Accessed February 11, 2021.https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin